Correction to: Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a subanalysis of the ALTTO trial (BIG 206; NCCTG (Alliance) N063D).
Breast Cancer Res Treat
; 191(1): 225, 2022 Jan.
Article
in En
| MEDLINE
| ID: mdl-34625860
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Breast Cancer Res Treat
Year:
2022
Document type:
Article
Affiliation country:
Brazil